Docrates Cancer Center

Recent papers from Docrates Cancer Center

1. Effects of Concomitant Medications on Clinical and Immunological Outcomes of Cancer Patients Treated With Oncolytic AdenovirusesInternational Journal of Cancer · 2026
2. First Systematic Mapping of Non-Target [68Ga]Ga-DOTANOC Uptake Across Anatomical Sites and EtiologiesBritish Journal of Radiology · 2026
3. Retrospective analysis of real-world clinical use of comprehensive genomic profiling in solid tumors in Finland 2017-2020ESMO Real World Data and Digital Oncology · 2026
4. Uneven Global Distribution of TheranosticsWorld Journal of Nuclear Medicine · 2026
5. 604P Pharmacokinetics, compliance and estradiol levels in women with breast cancer receiving elinzanetant for the treatment of endocrine therapy-associated vasomotor symptomsESMO Open · 2026
6. Fully intravenous split-dose administration of the oncolytic adenovirus TILT-123 in advanced solid tumorsMolecular Therapy · 2026
7. Pan-cancer ex vivo target evaluation of phosphodiesterase 3 A (PDE3A)Journal of Molecular Medicine · 2026
8. Evaluation of Radiotherapy Dose in Secondary Breast Angiosarcoma: Implications for PathogenesisAnticancer Research · 2026
9. WJNM with WARMTH: A Driving Force in Promoting Global Nuclear MedicineWorld Journal of Nuclear Medicine · 2026
10. Dyslipidemia-associated natural IgM improves oncolytic virus TILT-123 efficacy through antibody-dependent enhancement in solid tumorsMolecular Therapy · 2026
11. Exploratory biomarker analysis of RAS/BRAF somatic mutations and gene expression signatures for predicting treatment effects of aflibercept in the velour trialnpj Precision Oncology · 2026
12. Functional and molecular characterization of the first large cell neuroendocrine prostate cancer cell lineCurrent Molecular Pharmacology · 2026
13. Hepatic and Pulmonary Vasoactive Response Triggered by Potentially Hazardous Chemicals After Passing Through the Gut MucosaDiagnostics · 2025
14. Is Exercise During Androgen Deprivation Therapy Effective and Safe? A Randomized Controlled TrialScandinavian Journal of Medicine and Science in Sports · 2025
15. Multicentre evaluation of deep learning CT autosegmentation of the head and neck region for radiotherapyTyöväentutkimus Vuosikirja · 2025
16. Single-cell profiling of peripheral blood mononuclear cells from patients treated with oncolytic adenovirus TILT-123 reveals baseline immune status as a predictor of therapy outcomesCancer Gene Therapy · 2025
17. Management Based on Pretreatment PSMA PET of Patients with Localized High-Risk Prostate Cancer Part 2: Prediction of Recurrence—A Systematic Review and Meta-AnalysisCancers · 2025
18. Real-World Observational Study of Incidence and Outcomes in an HR+/HER2– Early Breast Cancer Population with High-Risk of Recurrence in FinlandOncology and Therapy · 2025
19. The oncolytic adenovirus TILT-123 with pembrolizumab in platinum resistant or refractory ovarian cancer: the phase 1a PROTA trialNature Communications · 2025
20. Transient lymphocyte count decrease correlates with oncolytic adenovirus efficacy in humans: mechanistic and biomarker findings from TUNIMO phase I trialJournal for ImmunoTherapy of Cancer · 2025